首页> Heliyon> The value of serum HE4 and CA125 levels for monitoring the recurrence and risk stratification of endometrial endometrioid carcinoma.

The value of serum HE4 and CA125 levels for monitoring the recurrence and risk stratification of endometrial endometrioid carcinoma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Sainan,Gong

第一单位： Department of Gynecology, The First Affiliated Hospital of Chongqing Medical University, 400016 Chongqing, PR China.

作者： Sainan,Gong ^[1] ; Quan,Quan ^[2] ; Yu,Meng ^[3] ; Jingxian,Wu ^[4] ; Shuang,Yang ^[1] ; Jiaming,Hu ^[1] ; Xiaoling,Mu ^[1]

作者单位： Department of Gynecology, The First Affiliated Hospital of Chongqing Medical University, 400016 Chongqing, PR China. ^[1] Department of Gynecology, The First People's Hospital of Chongqing Liangjiang New Area, 401121 Chongqing, PR China. ^[2] Department of Physical Examination Center, University Town Hospital Affiliated to Chongqing Medical University, 400042 Chongqing, PR China. ^[3] Department of Pathology, The First Affiliated Hospital of Chongqing Medical University, 400016 Chongqing, PR China. ^[4]

关键词 CA125 Endometrial endometrioid carcinoma HE4 Monitoring Prediction Risk stratification

DOI 10.1016/j.heliyon.2023.e18016

PMID 37519747

发布时间 2023-08-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Heliyon

2023年9卷7期

e18016页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Heliyon

2023年9卷7期

e18016页

检索历史清除

The value of serum HE4 and CA125 levels for monitoring the recurrence and risk stratification of endometrial endometrioid carcinoma.

Heliyon

相似文献

同项目论文

Heliyon

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The value of serum HE4 and CA125 levels for monitoring the recurrence and risk stratification of endometrial endometrioid carcinoma.

Heliyon

相似文献

同项目论文

Heliyon

相关期刊

检索历史清除